Abstract:Although resveratrol exerts manifold antitumorigenic effects in vitro, its efficacy against malignancies in vivo seems limited. This has been increasingly recognized in recent years and has prompted scientists to search for structurally related compounds with more promising anticarcinogenic and/or pharmacokinetic properties. A class of structurally modified resveratrol derivatives, so-called resveratrol imine analogs (IRA’s), might meet these requirements. Therefore, the biological activity of five of these compounds was examined and compared to that of resveratrol. Firstly, the antiproliferative potency of all five IRA’s was investigated using the p53 wildtype-carrying colorectal carcinoma cell line HCT-116wt. Then, using the former and a panel of various other tumor cell lines (including the p53 knockout variant HCT-116p53-/-), the growth-inhibiting and cell cycle-disturbing effects of the most potent IRA (IRA 5, 2-[[(2-hydroxyphenyl)methylene]amino]-phenol) were studied as was its influence on cyclooxygenase-2 expression and activity. Finally, rat liver microsomes were used to determine the metabolic stability of that compound. IRA 5 was clearly the most potent compound in HCT-116wt cells, with an unusually high IC50-value of 0.6 μM. However, in the other five cell lines used, the antiproliferative activity was mostly similar to resveratrol and the effects on the cell cycle were heterogeneous. Although all cell lines were affected by treatment with IRA 5, cells expressing functional p53 seemed to react more sensitively, suggesting that this protein plays a modulating role in the induction of IRA 5-mediated biological effects. Lastly, IRA 5 led to contradictory effects on cyclooxygenase-2 expression and activity and was less glucuronidated than resveratrol. As IRA 5 is approximately 50 times more toxic towards HCT-116wt cells, exerts different effects on the cyclooxygenase-2 and is metabolized to a lesser extent, it shows certain advantages over resveratrol and could therefore serve as basis for additional chemical modifications, potentially yielding compounds with more favorable biological and pharmacokinetic features.

Imine Resveratrol Analogues: Molecular Design, Nrf2 Activation And Sar Analysis

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

The Antioxidant Effect of Imine Resveratrol Analogues

Design, Synthesis and Biological Evaluation of a Series of New Resveratrol Analogues As Potential Anti-Cancer Agents

Synthesis and Estrogen-Like Activity of Resveratrol Analogues

The Design, Synthesis, and Anti-Tumor Mechanism Study of N-phosphoryl Amino Acid Modified Resveratrol Analogues.

Design, Synthesis, and Structure Activity Relationship (SAR) Studies of Novel Imidazo[1,2-A] Pyridine Derivatives As Nek2 Inhibitors

Design, Synthesis and Biological Evaluation of Novel Indone Derivatives As Selective ERβ Modulators

Growth-Inhibiting Activity of Resveratrol Imine Analogs on Tumor Cells in Vitro

Discovery of oxime-bearing naphthalene derivatives as a novel structural type of Nrf2 activators

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Synthetic Imine Resveratrol Analog 2-Methoxyl-3,6-dihydroxyl-ira Ameliorates Colitis by Activating Protective Nrf2 Pathway and Inhibiting NLRP3 Expression.

Design, synthesis and evaluation of antioxidant and anti-inflammatory activities of novel resveratrol derivatives as potential multifunctional drugs

Synthesis of Rseveratrol Analogues

Synthesis and cytotoxic evaluation of a series of resveratrol derivatives.

Synthesis Of Resveratrol Analogues, And Evaluation Of Their Cytotoxic And Xanthine Oxidase Inhibitory Activities

Discovery of 4-Anilinoquinolinylchalcone Derivatives as Potential NRF2 Activators

Design, synthesis, antioxidant and antitumor activity of some 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one-resveratrol hybrids

Synthesis and Cytotoxic Evaluation of A Series of Resveratrol Derivatives Modified in C2 Position

Design, Synthesis and Biological Evaluation of Chrysin Long-Chain Derivatives As Potential Anticancer Agents

Anti-inflammatory and antioxidant properties of a novel resveratrol-salicylate hybrid analog